Princeton Global Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Princeton Global Asset Management's ELV Position: Q2 2026 in Review
Princeton Global Asset Management increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $3.71K and bringing the position to 58 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #465.
Princeton Global Asset Management first reported a position in ELV in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.53M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Princeton Global Asset Management held 58 shares of Elevance Health worth $22.5K as of Q2 2026.
- Princeton Global Asset Management bought 10 Elevance Health shares in Q2 2026, an estimated $3.71K.
- Elevance Health made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #465 holding.
- Princeton Global Asset Management first reported a position in Elevance Health in Q4 2019 and has held it in 17 quarters since.
- Princeton Global Asset Management's Elevance Health position peaked at $3.53M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.